LY4088044 Clinical Trials (2026): 1 Studies for Healthy
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 LY4088044 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Healthy) and 104 total planned enrollment. 1 LY4088044 clinical trial is actively recruiting at 2 U.S. sites across 2 states. Most recent activity: NCT07090785 (Jul 2027).
Where to Participate: All LY4088044 Trial Sites in the U.S. (2 sites across 2 states)
Every actively recruiting LY4088044trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| TX | ICON Early Phase Services | San Antonio78232 | NCT07090785 | Map |
| UT | ICON | Salt Lake City84124 | NCT07090785 | Map |
LY4088044 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P1 | 1 | 1 |
Recruiting LY4088044 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07090785 | A Study of LY4088044 in Healthy Participants | P1 | Healthy | 104 | Jul 2025 |
All LY4088044 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07090785 | A Study of LY4088044 in Healthy Participants | P1 | recruiting | 104 | Eli Lilly and Company | Jul 2025 |
LY4088044 clinical trials: frequently asked questions
- How many LY4088044 clinical trials are there?
- 1 LY4088044 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are LY4088044 clinical trials recruiting in 2026?
- Yes — 1 LY4088044 trial is actively recruiting in 2026, with 2 U.S. sites across 2 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is LY4088044 being studied for?
- LY4088044 is being studied for Healthy. The trials are grouped by indication on this page.
- What phase is LY4088044 in?
- LY4088044 clinical trials span 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors LY4088044 clinical trials?
- The lead sponsor across the most LY4088044 trials is Eli Lilly and Company. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming LY4088044as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: